Breast Cancer Recurrence, Screening Test before Chemotherapy, India

Scientific Publications

Bakre, M. M., et al. (2019). Clinical validation of an immunohistochemistry-based CanAssist Breast test for distant recurrence prediction in hormone receptor-positive breast cancer patients.Cancer medicine 1-10. doi: 10.1002/cam4.2049

Attuluri., A. K., et al (2019). Analytical Validation of the immunohistochemistry-based CanAssist Breast Prognostic Test for Prediction of Risk of Recurrence in Hormone Receptor- Positive Breast Cancer. BMC Cancer 19:249. doi: 10.1186/s12885-019-5443-5

Ramkumar, C., et al. (2018). Development of a Novel Proteomic Risk-Classifier for Prognostication of Patients With Early-Stage Hormone Receptor–Positive Breast Cancer. Biomarker insights, 13, 1177271918789100. doi: 10.1177/1177271918789100

Prakash, C., et al. (2018). Risk stratification in early-stage estrogen receptor+ /HER2-breast cancer patients: Comparative analysis of cost-effective methods

Somashekhar, S., et al. (2017). 1675P Risk of recurrence prediction and optimum treatment planning for early-stage breast cancer patients: A cost-effective, accurate and broad based solution for Asia

Ramkumar, C., et al. (2017). Assessment of Ki67 As a Prognostic Marker in Hormone Receptor Positive Breast Cancer: A Retrospective Study

Copyright © 2019, OncoStem. All rights reserved Disclaimer